Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 52% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 10338.49 | 226 / 226 | 91% | 101.63 | 368 / 406 |
brain | 84% | 289.20 | 2210 / 2642 | 84% | 2.14 | 594 / 705 |
esophagus | 93% | 237.95 | 1340 / 1445 | 51% | 1.19 | 93 / 183 |
thymus | 97% | 262.45 | 632 / 653 | 38% | 0.67 | 228 / 605 |
breast | 97% | 316.04 | 447 / 459 | 36% | 0.73 | 402 / 1118 |
ovary | 98% | 363.78 | 177 / 180 | 32% | 0.62 | 137 / 430 |
stomach | 97% | 242.34 | 349 / 359 | 31% | 0.63 | 90 / 286 |
skin | 97% | 361.89 | 1761 / 1809 | 28% | 0.52 | 131 / 472 |
prostate | 96% | 223.61 | 234 / 245 | 26% | 0.44 | 131 / 502 |
intestine | 99% | 360.57 | 957 / 966 | 22% | 0.55 | 118 / 527 |
pancreas | 97% | 201.75 | 317 / 328 | 24% | 0.45 | 43 / 178 |
lung | 91% | 245.32 | 527 / 578 | 30% | 0.58 | 341 / 1155 |
uterus | 98% | 375.05 | 167 / 170 | 19% | 0.30 | 86 / 459 |
kidney | 79% | 115.47 | 70 / 89 | 36% | 0.79 | 321 / 901 |
adrenal gland | 89% | 154.97 | 230 / 258 | 22% | 0.37 | 51 / 230 |
bladder | 90% | 262.48 | 19 / 21 | 17% | 0.35 | 86 / 504 |
spleen | 100% | 302.02 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 255.15 | 1290 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 178.93 | 774 / 803 | 0% | 0 | 0 / 0 |
adipose | 93% | 224.42 | 1117 / 1204 | 0% | 0 | 0 / 0 |
heart | 72% | 97.39 | 616 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 40% | 74.42 | 374 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.24 | 5 / 29 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.26 | 7 / 45 |
eye | 0% | 0 | 0 / 0 | 10% | 0.18 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006958 | Biological process | complement activation, classical pathway |
GO_0001867 | Biological process | complement activation, lectin pathway |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0001855 | Molecular function | complement component C4b binding |
GO_0008233 | Molecular function | peptidase activity |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | MASP2 |
Protein name | MBL associated serine protease 2 Mannan-binding lectin serine protease 2 (EC 3.4.21.104) (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2) (MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain] |
Synonyms | |
Description | FUNCTION: Serum protease that plays an important role in the activation of the complement system via mannose-binding lectin. After activation by auto-catalytic cleavage it cleaves C2 and C4, leading to their activation and to the formation of C3 convertase. . |
Accessions | A0A8V8TPN9 O00187 ENST00000400898.3 [O00187-2] A0A8V8TQL6 ENST00000400897.8 [O00187-1] ENST00000700094.1 A0A8V8TQY3 A0A8V8TPN3 ENST00000700095.1 A0A8V8TPA2 A0A8V8TP45 A0A8V8TPU1 ENST00000700089.1 ENST00000700096.1 ENST00000700097.1 ENST00000699958.1 A0A8V8TQY5 ENST00000700092.1 ENST00000700088.1 ENST00000700090.1 A0A8V8TQL2 ENST00000700091.1 A0A8V8TPT6 ENST00000700093.1 |